S&P 500   4,330.00 (-1.64%)
DOW   34,070.42 (-1.08%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.45 (-4.20%)
BABA   84.11 (-1.90%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.29%)
MU   67.90 (-2.55%)
CGC   0.77 (-12.02%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
S&P 500   4,330.00 (-1.64%)
DOW   34,070.42 (-1.08%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.45 (-4.20%)
BABA   84.11 (-1.90%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.29%)
MU   67.90 (-2.55%)
CGC   0.77 (-12.02%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
S&P 500   4,330.00 (-1.64%)
DOW   34,070.42 (-1.08%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.45 (-4.20%)
BABA   84.11 (-1.90%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.29%)
MU   67.90 (-2.55%)
CGC   0.77 (-12.02%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
S&P 500   4,330.00 (-1.64%)
DOW   34,070.42 (-1.08%)
QQQ   357.86 (-1.83%)
AAPL   173.93 (-0.89%)
MSFT   319.53 (-0.39%)
META   295.73 (-1.31%)
GOOGL   130.44 (-2.47%)
AMZN   129.33 (-4.41%)
TSLA   255.70 (-2.62%)
NVDA   410.17 (-2.89%)
NIO   8.45 (-4.20%)
BABA   84.11 (-1.90%)
AMD   96.11 (-4.22%)
T   15.31 (-1.61%)
F   12.20 (-1.29%)
MU   67.90 (-2.55%)
CGC   0.77 (-12.02%)
GE   112.97 (-1.64%)
DIS   82.73 (+0.21%)
AMC   7.71 (-5.51%)
PFE   32.85 (-2.29%)
PYPL   58.62 (-3.68%)
NFLX   384.15 (-0.56%)
NASDAQ:VANI

Vivani Medical (VANI) Stock Forecast, Price & News

$0.94
+0.05 (+5.62%)
(As of 09/21/2023 ET)
Compare
Today's Range
$0.89
▼
$0.96
50-Day Range
$0.88
▼
$1.30
52-Week Range
$0.75
▼
$2.64
Volume
28,798 shs
Average Volume
54,111 shs
Market Capitalization
$47.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Vivani Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
644.7% Upside
$7.00 Price Target
Short Interest
Healthy
0.75% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.00mentions of Vivani Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$164,705 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.41 out of 5 stars

Medical Sector

236th out of 961 stocks

Electromedical Equipment Industry

6th out of 22 stocks

See Top Rated MarketRank™ Stocks Here

VANI stock logo

About Vivani Medical (NASDAQ:VANI) Stock

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

VANI Price History

VANI Stock News Headlines

September 19, 2023 | benzinga.com
Vivani Medical Director Trades $97K In Company Stock
September 13, 2023 | finance.yahoo.com
Director Gregg Williams Acquires 13,997 Shares of Vivani Medical Inc (VANI)
September 21, 2023 | Behind the Markets (Ad)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
September 13, 2023 | americanbankingnews.com
Analyzing Vivani Medical (VANI) and Its Peers
September 12, 2023 | americanbankingnews.com
Financial Review: Vivani Medical (VANI) vs. Its Rivals
September 12, 2023 | americanbankingnews.com
Head-To-Head Survey: Vivani Medical (VANI) versus Its Rivals
September 11, 2023 | americanbankingnews.com
Vivani Medical (VANI) versus Its Peers Head-To-Head Comparison
September 10, 2023 | finance.yahoo.com
Insider Buys Additional US$50k In Vivani Medical Stock
September 21, 2023 | The Oxford Club (Ad)
Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
September 8, 2023 | benzinga.com
50K Reasons To Be Bullish On Vivani Medical Stock
September 8, 2023 | msn.com
Vivani Medical Director William Gregg buys $50.2k worth of shares - filing
September 7, 2023 | finance.yahoo.com
Vivani Medical to Present at the Boulder Peptide Symposium
September 5, 2023 | finance.yahoo.com
Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10
August 16, 2023 | markets.businessinsider.com
Maxim Group Reaffirms Their Buy Rating on Vivani Medical (VANI)
August 14, 2023 | seekingalpha.com
Vivani Medical GAAP EPS of -$0.13 misses by $0.02
August 14, 2023 | chron.com
Vivani Medical: Q2 Earnings Snapshot
August 14, 2023 | finance.yahoo.com
Vivani Medical Reports Second Quarter Financial Results and Provides Business Update
July 11, 2023 | finance.yahoo.com
Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System
June 23, 2023 | benzinga.com
Director at Vivani Medical Acquires Company Stock Options Worth 32,121 Shares
June 21, 2023 | benzinga.com
Board Member at Vivani Medical Acquires Company Stock Options Worth 32,121 Shares
June 21, 2023 | benzinga.com
Vivani Medical Director Awarded $39K Worth of Stock Options
June 14, 2023 | finance.yahoo.com
Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
June 13, 2023 | finance.yahoo.com
Is Vivani Medical (NASDAQ:VANI) In A Good Position To Invest In Growth?
June 8, 2023 | seekingalpha.com
IPO Update: Cortigent Readies $15 Million Mini-IPO
June 8, 2023 | msn.com
Cortigent, vision restoration device maker, sets terms for $15M IPO
June 6, 2023 | uk.finance.yahoo.com
VANI - Vivani Medical, Inc.
May 15, 2023 | sfgate.com
Vivani Medical: Q1 Earnings Snapshot
See More Headlines
Receive VANI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vivani Medical and its competitors with MarketBeat's FREE daily newsletter.

VANI Company Calendar

Last Earnings
8/14/2023
Today
9/21/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:VANI
CUSIP
N/A
CIK
1266806
Web
www.vivani.com
Phone
(818) 833-5000
Fax
818-833-5067
Employees
50
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.00
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+644.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.39)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-13,890,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-44.95%
Return on Assets
-35.23%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.11
Quick Ratio
5.11

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.87 per share
Price / Book
1.08

Miscellaneous

Outstanding Shares
50,819,000
Free Float
22,553,000
Market Cap
$47.75 million
Optionable
Optionable
Beta
2.64
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Adam Mendelsohn Ph.D. (Age 41)
    CEO & Director
    Comp: $312.01k
  • Ms. Brigid Ann Makes (Age 67)
    Chief Financial Officer
    Comp: $204.63k
  • Mr. Truc Le M.B.A. (Age 70)
    Chief Operations Officer
    Comp: $337.2k
  • Dr. Lisa E. Porter M.D. (Age 59)
    Chief Medical Officer
  • Mr. Donald Dwyer M.B.A.
    Chief Bus. Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













VANI Stock - Frequently Asked Questions

Should I buy or sell Vivani Medical stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vivani Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" VANI shares.
View VANI analyst ratings or view top-rated stocks.

What is Vivani Medical's stock price forecast for 2023?

1 equities research analysts have issued 1 year target prices for Vivani Medical's stock. Their VANI share price forecasts range from $7.00 to $7.00. On average, they expect the company's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 644.9% from the stock's current price.
View analysts price targets for VANI or view top-rated stocks among Wall Street analysts.

How have VANI shares performed in 2023?

Vivani Medical's stock was trading at $0.8497 at the start of the year. Since then, VANI stock has increased by 10.6% and is now trading at $0.9397.
View the best growth stocks for 2023 here.

When is Vivani Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our VANI earnings forecast.

How were Vivani Medical's earnings last quarter?

Vivani Medical, Inc. (NASDAQ:VANI) announced its earnings results on Monday, August, 14th. The company reported ($0.13) earnings per share for the quarter.

What is Vivani Medical's stock symbol?

Vivani Medical trades on the NASDAQ under the ticker symbol "VANI."

Who are Vivani Medical's major shareholders?

Vivani Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Tanager Wealth Management LLP (3.25%), BlackRock Inc. (0.42%), Geode Capital Management LLC (0.28%), Charles Schwab Investment Management Inc. (0.06%), Cutler Group LLC CA (0.00%) and Citadel Advisors LLC (0.00%). Insiders that own company stock include Aaron Mendelsohn, Brigid Makes, Donald Dwyer, Gregg Williams and Joachim Eberhard Bolck.
View institutional ownership trends.

How do I buy shares of Vivani Medical?

Shares of VANI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vivani Medical's stock price today?

One share of VANI stock can currently be purchased for approximately $0.94.

How much money does Vivani Medical make?

Vivani Medical (NASDAQ:VANI) has a market capitalization of $47.75 million. The company earns $-13,890,000.00 in net income (profit) each year or ($0.39) on an earnings per share basis.

How can I contact Vivani Medical?

Vivani Medical's mailing address is 13170 TELFAIR AVE., SYLMAR CA, 91342. The official website for the company is www.vivani.com. The company can be reached via phone at (818) 833-5000, via email at investors@secondsight.com, or via fax at 818-833-5067.

This page (NASDAQ:VANI) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -